Healthcare
North America Frac Sand, Inc.(NAFS)
Live Price
Offline$0.7001
+0.00% today
Window Change
-72.00%
Window
Jun 26, 2025 → May 13, 2026
- Market Cap
- $50.00M
- Revenue Growth
- +37.1%
- EPS Growth
- +30.0%
- Dividend Yield
- 0.0%
Coverage: 199 bars · Jun 26, 2025 → May 13, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
North America Frac Sand, Inc. (NAFS) is a Healthcare stock with a market cap of $50.00M and listed on OTC. The stock last traded around $0.70 and down 72.0% across the available one-year price window (Jun 26, 2025 → May 13, 2026). Baseline metrics include revenue growth of +37.1%, EPS growth of +30.0%, a dividend yield of 0.0%. What stands out right now is revenue +37.1%, EPS +30.0%, free cash flow +82.3% with operating margin -231.2% and ROIC 24.5%. Valuation already assumes a fairly strong business story at price/sales 372.5. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines NAFS price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+37.1% vs +7.6% peer median
Operating Margin
Below sector median
-231.2% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
The operating story is still moving forward
Revenue is running at +37.1% and EPS at +30.0%, with operating margin around -231.2%.
Benchmark Edge
NAFS vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
NAFS
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
NAFS Max Drawdown
-100.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for NAFS and SPY.
Company Overview
North America Frac Sand, Inc.
Other OTC
North America Frac Sand, Inc., doing business as Voycare, provides telemedicine and medical tourism services in the United States. It enables overseas patients gain access to health care primarily in the fields of oncology, in vitro fertilization, cosmetic surgery, and wellness. The company primarily serves Chinese outbound travelers to North and South America. The company was founded in 2019 and is based in Covina, California with office in Shanghai, China.
- Leadership
- Abdiel Castrellon
- IPO Date
- Apr 3, 2013
- Employees
- 4
- Street Address
- 1274 Center Court Drive
- Mailing
- Hollywood, CA, 91724
- Region
- Hollywood, CA, US
- Reporting Currency
- USD
- Investor Line
- +1 306 693 4233
- Last Updated
- May 2, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- —
- EV/EBITDA
- —
- Price/Sales
- 372.5
- Price/Book
- —
Growth
- Revenue
- +37.1%
- EPS
- +30.0%
- Free Cash Flow
- +82.3%
Profitability
- Gross Margin
- 79.3%
- Operating Margin
- -231.2%
- Net Margin
- -386.3%
- ROE
- 31.0%
- ROIC
- 24.5%
Balance Sheet
- Debt/Equity
- —
- Current Ratio
- 0.12
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.